JB Chemicals & Pharmaceuticals Ltd (JBCPL) enters the Nephrology segment in India, launches Renova Division Ruchika Sharma7 May 2021 5:09 PM ISTMumbai: J.B. Chemicals & Pharmaceuticals Ltd. announced its foray into the area of Nephrology with a new dedicated division called "RENOVA" which...
FDA Approves dapagliflozin for treating Chronic Kidney Disease Dr Kartikeya Kohli1 May 2021 7:46 AM ISTThe U.S. Food and Drug Administration has approved dapagliflozin oral tablets to reduce the risk of kidney function decline, kidney failure,...
TAVR associated with improved kidney function in aortic stenosis patients: Study Medha Baranwal14 April 2021 5:00 AM ISTUSA: Chronic kidney disease (CKD) stage is more likely to improve than worsen in severe aortic stenosis patients with renal disease undergoing TAVR,...
Peritoneal Dialysis is significantly improving patient outcomes: Experts hina15 March 2021 1:15 PM ISTNon-communicable diseases (NCDs) pose an increasingly large threat to the world today. What is more alarming is that India is one of the countries ...
New BP lowering guidelines could benefit 25 million americans with CKD Hina Zahid25 Feb 2021 3:30 AM ISTA recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in...
High dose Telmisartan may help reduce proteinuria in CKD Patients: Study Dr Kartikeya Kohli16 Feb 2021 6:55 PM ISTRenoprotective therapy, including inhibition of the renin-angiotensin system (RAS), in patients with chronic kidney disease (CKD) is important to...
One Hyperkalemia event in CKD predisposes to risk of subsequent hyperkalemia events Dr Kartikeya Kohli9 Feb 2021 10:00 AM ISTHigh serum potassium concentration (HK) is due to impaired renal function and are commonly seen in Chronic Kidney Disease (CKD) patients. A study...
AstraZeneca gets DCGI nod for Dapagliflozin tablets to treat chronic kidney disease Ruchika Sharma8 Feb 2021 11:34 AM ISTNew Delhi: AstraZeneca Pharma India on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for Dapagliflozin...
Zydus Cadila completes patient enrolment for 2 Phase III trials of Desidustat Ruchika Sharma6 Feb 2021 10:00 AM ISTAhmedabad: Zydus Cadila, global pharmaceutical company, has recently announced that the company has completed patient enrolment in DREAM-ND and...
High magnesium increases risk of death, CV events in CKD patients: Study Dr Kartikeya Kohli25 Jan 2021 10:45 PM ISTSpain: Magnesium supplementation to patients with chronic kidney disease (CKD) should be considered with caution, suggests results from a recent study...
Metformin has cardiorenal safety in diabetics with CKD but may not decrease MACE Dr. Nandita Mohan21 Jan 2021 10:44 AM ISTResearchers have recently found that participants with chronic kidney disease from two cardiovascular outcomes trials support the cardiorenal safety...
AstraZeneca gets CDSCO nod for Dapagliflozin in CKD MD Bureau17 Jan 2021 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), operative under the Central Drugs Standard Control Organization (CDSCO), has given its nod to...
